Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revolution Medicines, Inc. (RVMD)  
$35.59 0.67 (1.85%) as of 4:30 Wed 4/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 163,810,000
Market Cap: 5.83(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.35 - $37.41
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 950,000
Total Buy Value $0 $0 $0 $20,145,604
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 4
Total Shares Sold 58,164 137,415 322,875 793,034
Total Sell Value $1,972,591 $4,176,412 $10,218,319 $19,743,299
Total People Sold 6 6 7 10
Total Sell Transactions 11 23 44 64
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 334
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Patel Sushil   •       •      –    2024-04-10 4 AS $37.00 $79,735 D/D (2,155) 15,700 -4%     
   Patel Sushil   •       •      –    2024-04-10 4 OE $16.80 $36,204 D/D 2,155 17,855     -
   Goldsmith Mark A See Remarks   •       •      –    2024-04-10 4 AS $35.33 $353,346 I/I (10,000) 30,424 -4%     
   Goldsmith Mark A See Remarks   •       •      –    2024-04-10 4 AS $35.48 $266,122 D/D (7,500) 452,879 -4%     
   Cislini Jeff General Counsel   •       •      –    2024-03-27 4 AS $30.38 $46,481 D/D (1,500) 54,374 10%     
   Wei Lin Chief Medical Officer   •       –      –    2024-03-21 3 IO $0.00 $0 D/D 0 74,400 12%     
   Anders Jack Chief Financial Officer   •       •      –    2024-03-18 4 AS $31.58 $39,826 D/D (1,261) 101,959 13%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-18 4 AS $31.58 $92,033 D/D (2,914) 139,553 13%     
   Goldsmith Mark A See Remarks   •       •      –    2024-03-18 4 AS $31.58 $182,804 D/D (5,788) 460,379 13%     
   Cislini Jeff General Counsel   •       •      –    2024-03-18 4 AS $31.58 $39,542 D/D (1,252) 55,874 13%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-03-18 4 AS $31.58 $67,051 D/D (2,123) 270,909 13%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-12 4 AS $34.07 $270,345 D/D (7,936) 142,467 4%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-12 4 OE $4.09 $32,458 D/D 7,936 150,403     -
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-11 4 AS $34.02 $535,306 D/D (15,735) 142,467 6%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-11 4 OE $4.09 $64,356 D/D 15,735 158,202     -
   Wang Xiaolin See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 24,200 84,526     -
   Anders Jack Chief Financial Officer   •       •      –    2024-03-01 4 A $0.00 $0 D/D 26,400 103,220     -
   Cislini Jeff General Counsel   •       •      –    2024-03-01 4 A $0.00 $0 D/D 21,000 57,126     -
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-01 4 A $0.00 $0 D/D 41,000 142,467     -
   Kelsey Stephen Michael See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 51,400 273,032     -
   Goldsmith Mark A See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 90,000 466,167     -
   Cislini Jeff General Counsel   •       •      –    2024-01-22 4 AS $27.00 $40,500 D/D (1,500) 36,126 27%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-01-08 4 AS $29.01 $96,809 D/D (3,337) 221,632 19%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-01-02 4 AS $29.10 $387,884 D/D (13,330) 224,969 24%     
   Kelsey Stephen Michael See Remarks   •       •      –    2023-12-27 4 AS $29.01 $966,996 D/D (33,334) 238,299 19%     
  334 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us